Skip to content

Clinical trials

Completed Phase 2 Pathologic Complete Response trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pathologic Complete Response Phase: Phase 2 Status: Completed Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20112
20122
20201
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Lucia Del Mastro,MD1
M.D. Anderson Cancer Center1
Millennium Pharmaceuticals, Inc.1
Ruijin Hospital1
Sellas Life Sciences Group1
Shanghai Jiao Tong University School of Medicine1
University Hospital Tuebingen1
Zhejiang Cancer Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pathologic Complete Response8
Breast Neoplasms2
Neoplasm Metastasis2
Carcinoma, Non-Small-Cell Lung1
Carcinoma, Renal Cell1
Esophageal Squamous Cell Carcinoma1
Hyperthermia1
Kidney Neoplasms1
Leukemia, Myeloid, Acute1
Pathological Conditions, Signs and Symptoms1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.